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SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of copper chelate of L-lysinate-
HCl as feed additive for all animal species
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Copper chelate of L-lysinate-HCl, provided as powder and as granulate, is intended for use as a copper source in 
animal nutrition. Tolerance studies with chicken for fattening and weaned piglets, allowed the FEEDAP Panel to 
conclude that copper chelate of L-lysinate-HCl is a safe source of copper for all animal species, provided that the 
maximum copper contents authorised in feed are respected. The supplementation of feeds with copper from 
copper chelate of  L-lysinate-HCl up to the maximum authorised copper levels is not expected to result in a 
different  copper  deposition  in  edible  tissues/products  than  the  standard  inorganic  source  cupric  sulphate 
pentahydrate.  No  concerns  for  consumer  safety  will  arise  from  the  use  of  the  additive  in  animal  nutrition, 
provided that the maximum copper contents authorised in feed are respected. The powder form of copper chelate 
of L-lysinate-HCl should be considered as a risk by inhalation; exposure by inhalation should be minimised. 
Neither form of the additive is a dermal irritant but the powder form is an eye irritant. In the absence of data, it is 
considered  prudent  to  regard  both  forms  as  potential  skin  sensitisers.  Copper  chelate  of  L-lysinate-HCl  is 
intended  to  be  a  substitute  for  other  authorised  copper  additives;  it  will  therefore  not  further  increase  the 
environmental  burden  from  copper.  Copper  chelate  of  L-lysinate-HCl  is  an  efficacious  source  of  copper  in 
meeting animal requirements. The Panel made some recommendations regarding the Description and Conditions 
of use of the additive and the maximum residue limits established for copper in animal tissues and products. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of copper chelate of  L-lysinate-HCl for all animal species. The additive is intended to be 
marketed in two forms, powder and granules. 
Tolerance  studies  with  chicken  for  fattening  and  weaned  piglets,  allowed  the  FEEDAP  Panel  to 
conclude that  copper  chelate  of  L-lysinate-HCl  is  a  safe source  of  copper for  all  animal  species, 
provided that the maximum copper contents authorised in feed are respected. 
The supplementation of feeds with copper from copper chelate of l-lysinate-HCl up to the maximum 
authorised  copper  levels  is  not  expected  to  result  in  a  different  copper  deposition  in  edible 
tissues/products than the standard inorganic source cupric sulphate pentahydrate. No concerns for 
consumer safety will arise from the use of the additive in animal nutrition, provided that the maximum 
copper contents authorised in feed are respected.  
The powder form of copper chelate of l-lysinate-HCl should be considered as a risk by inhalation; 
exposure by inhalation should be minimised. Neither form of the additive is a dermal irritant but the 
powder form is an eye irritant. In the absence of data, it is considered prudent to regard both forms as 
potential skin sensitisers. 
Copper chelate of L-lysinate-HCl is intended to be a substitute for other authorised copper additives; it 
will therefore not further increase the environmental burden from copper. 
In one study in chickens, dietary copper chelate of L-lysinate-HCl increased the copper concentration 
in liver in a dose-dependent manner comparable to a standard authorised copper source; an additional 
study in chickens also supported the bioavailability of copper from a copper-lysine complex. It is 
therefore concluded that copper chelate of  L-lysinate-HCl is an effective source of copper for all 
animal species. 
The  Panel  made  some  recommendations  regarding  the  Description  and  Conditions  of  use  of  the 
additive  and  the  maximum  residue  limits  established  for  copper  in  animal  tissues  and  products.Aminotrace Copper Bislysinate for all animal species 
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7. 
The European Commission received a request from the company Senzyme GmbH
5 for authorisation of 
the product  copper chelate of  L-lysinate-HCl, when used as a feed additive for all animal species 
(category: Nutritional additives; functional group: compounds of trace elements) under the conditions 
mentioned in Table 1. 
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation  of  a  feed  additive  or  new  use  of  a  feed  additive).
6  According to Article 8 of that 
Regulation, EFSA, after verifying the particulars and documents submitted by the applicant, shall 
undertake an assessment in order to determine whether the feed additive complies with the conditions 
laid down in Article 5. The particulars and documents in support of the application were considered 
valid by EFSA as of 25 September 2013. 
The feed additive Aminotrace Copper Bislysinate has not been previously authorised in the European 
Union (EU). Several other copper compounds are authorised in the EU to be used as nutritional feed 
additives (trace elements): cupric acetate, monohydrate; basic cupric carbonate, monohydrate; cupric 
chloride, dihydrate; cupric methionate; cupric oxide; cupric sulphate , pentahydrate; cupric chelate of 
amino acids hydrate; copperlysine sulphate;
7 cupric chelate of glycine, hydrate ;
8 copper chelate of 
hydroxy analogue of methionine;
9 dicopper chloride trihydroxide.
10 
The Scientific Committee on Animal Nutrition (SCAN) deli vered reports on the use of copper 
methionate for pigs (EC, 1981), copper compounds in feedingstuffs (EC, 1982) and in feedingstuffs 
for pigs (EC, 1983) and the use of copper in feedingstuffs (EC, 2003 a). EFSA issued opinions on the 
safety of the chelated  forms of iron, copper, manganese and zinc with synthetic feed grade glycine 
(EFSA, 2005), on the safety and efficacy of a copper chelate of hydroxy analogue of methionine 
(Mintrex
®Cu) as feed additive for all animal species (EFSA, 2008; EFSA FEEDAP Panel, 2009), and 
on the safety and efficacy of di copper chloride tri hydroxide (tribasic copper chloride, TBCC) as feed 
additive  for  all  animal  species  (EFSA  FEEDAP  Panel,  2011).  EFSA  has  issued  two  opinions 
concerning the re-evaluation of cupric sulphate pentahydrate (EFSA FEEDAP Panel, 2012) and cupric 
chelate of amino acids hydrate (EFSA FEEDAP Panel, 2013).  
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of copper chelate of 
L-lysinate-HCl, when used under the conditions described in Table 1. 
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5  Senzyme GmbH, Mülheimer Straße , 26 32, 53840 Troisdorf , Germany. 
6   EFSA Dossier reference: FAD-2013-0003. 
7  Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
additives in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11. 
8  Commission Regulation (EC) No 479/2006 of 23 March 2006 as regards the authorisation of certain additives belonging to 
the group compounds of trace elements. OJ L 86, 24.3.2006, p. 4. 
9  Commission Regulation (EU) No 349/2010 of 23 April 2010 concerning the authorisation of copper chelate of hydroxy 
analogue of methionine as a feed additive for all animal species. OJ L 104, 24.4.2010, p. 31. 
10   Commission Implementing Regulation (EU) No 269/2012 of 2 6 March 2012 concerning the authorisation of  dicopper 
chloride trihydroxide as feed additive for all animal species. OJ L 89, 27.3.2012, p. 3. Aminotrace Copper Bislysinate for all animal species 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   Aminotrace Copper Bislysinate 
Registration number/EC 
No/No (if appropriate)  - 
Category(-ies) of additive  nutritional additive, 3 
Functional group(s) of additive  compounds of trace elements, b 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Copper chelate from 
L-Lysinate HCl 
Cu(C6H13N2O2)2 
X HCl  
in compliance with EU 
legislation 
EN 15510:2007 
(copper) 
VDLUFA 4.11.6 
(L-Lysinate HCl) 
 
Trade name (if appropriate)  n.a. 
Name of the holder of 
authorisation (if appropriate)  n.a. 
 
Conditions of use 
Species  or 
category  of 
animal 
Maximum Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  mg/kg of complete feedingstuffs 
All animal species  -  - 
according 
Commission 
Regulation (EC) 
1334/3002 
n.a. 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for 
use (if appropriate) 
Feed formulation should be adjusted to account for the lysine 
activity of L-Lysinate HCl. 
A level of copper exceeding 10 mg/kg in feed may cause poisoning 
in certain breeds of sheep. 
A level of copper less than 20 mg/kg may cause deficiencies in 
cattle grazing pastures with high contents of molybdenum or sulfur. 
Specific conditions or restrictions for 
handling (if appropriate) 
For user safety: use safety glasses and protective gloves. In case of 
dust formation take appropriate measures for breathing protection. 
The  precautions  for  handling  on  the  safety  data  sheet  must  be 
observed. 
Post-market monitoring (if appropriate) 
Senzyme GmbH will conduct post-marketing monitoring in 
compliance with EU law on feed hygiene, namely by use of 
HACCP and Traceability systems and formal monitoring of 
customer feedback through product or service complaints. 
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
To supply copper in  final  feeds  within EU legal limits  for each 
species 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
n.a.  n.a.  n.a.  n.a. Aminotrace Copper Bislysinate for all animal species 
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ASSESSMENT 
1.  Introduction  
Copper is an essential trace element. The biological role of copper, its requirements/recommendations, 
deficiency and toxicity symptoms in farm animals have been described in a former opinion of the 
Scientific Committee on Animal Nutrition (SCAN) (EC, 2003a); the maximum levels authorised for 
total  copper  in  feedingstuffs  are  derived  from  that  opinion.  To  the  knowledge  of  the  Panel  on 
Additives and Products or Substances used in Animal Feed (FEEDAP), there is no additional relevant 
information that might lead it to modify the SCAN opinion. 
The applicant is seeking authorisation for the use of copper chelate of L-lysinate-HCl in feed for all 
animal  species/categories.  This  copper  compound  is  not  currently  authorised  in  the  EU  as  feed 
additive. 
2.  Characterisation  
For compounds of trace elements, the element itself is considered the active substance. 
2.1.  Characterisation of copper chelate of L-lysinate-HCl 
The additive copper chelate of L-lysinate-HCl is identified with the Chemical Abstracts Service (CAS) 
No 53383 2 7. Its International Union of Pure and Applied Chemistry (IUPAC) name is copper 
dichloro‐bis(L‐lysinate)‐complex.
11  Its  chemical formula  is  Cu(C6H13N2O2)2 × 2HCl,  and  it  has  a 
molecular weight of 426.83 Da. The theoretical content of copper is 14.9 %. 
The additive is intended to be marketed in two forms: powder, containing the additive as such, and 
granulate, with an admixture of approximately 0.5 % binding agents (e.g. carboxymethylcellulose). 
Both forms of the additive are specified to contain ≥ 14.5 % copper and ≤ 85.5 % L-lysine HCl. The 
analysis of five batches of each form was submitted. Average values for the powder were 14.6 ± 0.1 % 
Cu and 85.2 ± 0.2 % lysine HCl
12 and for the granulate were 14.6 ± 0.1 % Cu and 84.9 ± 0.1 % lysine 
HCl.
13 Absorbance data indicate that the additive consists of only copper chelate of L-lysinate-HCl.
14 
 A chemical structure of copper chelate of L-lysinate-HCl is shown in Figure 1. 
 
 
Figure 1:   Chemical structure of copper chelate of L-lysinate-HCl according to Duarte et al. (1985) 
Heavy metals (Cd, Pb, Hg), fluorine and arsenic, dioxins and dioxin like polychlorinated biphenyls 
(PCB’s)  were  analysed  in  three  batches  of  the  powder  form.
15,16  All  values  were  far  below  the 
                                                       
11 Other names: copper chelate from L‐Lysinate‐HCl, copper lysinate, copper bislysinate, di‐Lysinate, dichloro, coppersalt,  
  copper chelate of dichloro‐bis‐l‐lysinate. Trade name: Aminotrace Copper Bislysinate. 
12 Technical Dossier/Section II/Annex II_1_2  
13 Technical Dossier/Section II/Annex II_1_3  
14 Technical Dossier/Supplementary Information/Annex 2 
15 Technical Dossier/Section II/Annex II_1_4. 
16 Technical Dossier/Section II/Annex II_1_5. Aminotrace Copper Bislysinate for all animal species 
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thresholds of the directive on undesirable substances.
17 Mercury was below the limit of quantification 
(0.1 mg/kg additive). 
2.1.1.  Physical state of the product 
The product is dark grey-black in colour, has an unobtrusive odour and comes in two forms: a solid 
free-flowing  powder  or  granulates.  The  relative  density  for  the  powder  is  440  kg/m
3.
18  For the 
granulate form of the additive, the corresponding value is 400 kg/m
3.
19 
Mean particle size of the powder form was determined in three batches and was in the range of 43 48 
μm (v/v).
20 The samples contain 25 27 % of particulate matter with particle sizes < 10 μm; the dust 
contains 95 97 % particles < 10 μm. The granulate form has a mean particle size of 853 886 µm with 
virtually no particles below 10 µm.
21   
The dusting potential of the powder form as measured by the Stauber-Heubach method was 4.5 5.1 
g/m
3,
22 whereas the corresponding value for the granulate was 0.05 g/m
3.
23 
2.2.  Manufacturing process 
The starting raw materials used for the production of the additive are cupric oxide and L-lysine HCl. 
The manufacturing process of the product is fully described in the technical dossier.  
The material safety data sheets of the raw materials were provided:  L-lysine,
24 cupric oxide
25 and 
carboxymethylcellulose.
26 
2.3.  Stability and homogeneity 
Stability data of the additive were not provided by the applicant and are generally not required for 
compounds of trace elements. A minimum shelf life of one year is proposed by the applicant. 
The capacity of both forms of the additive to homogeneously distribute was presented in  studies 
conducted with a premixture for sows and with a variety of compound feedingstuffs (composition not 
given).
27 Based on the analysis of copper, the coefficients of variation were similar for the powder and 
granulate forms and ranged from 0.29 to 0.43 % in the premixture and from 0.21 to 6.4 % in feeds. The 
lowest deviation was obtained with mineral piglet feed and the highest one with pelleted piglet feed. 
2.4.  Conditions of use 
The  copper  compound  under  application,  copper  chelate  of  L-lysinate-HCl,  is  intended  to  supply 
copper in final feed for all animal species/categories up to a maximum total content of 170 mg Cu/kg 
in complete feedingstuffs for piglets (up to 12 weeks) and 25 mg Cu/kg for other pigs; 15 mg Cu/kg 
complete feedingstuffs for bovine before the start of rumination (milk replacers and other complete 
feedingstuffs) and 35 mg Cu/kg for other bovine; 15 mg Cu/kg complete feedingstuffs for ovine; 50 
mg Cu/kg complete feedingstuffs for crustaceans; 25 mg Cu/kg complete feedingstuffs for fish; and 25 
mg Cu/kg complete feedingstuffs for other species. 
                                                       
17 Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal 
  feed. OJ L 140, 30.5.2002, p. 10. 
18 Technical Dossier/Section II/Annex II_1_6.  
19 Technical Dossier/Section II/Annex II_1_9.  
20 Technical Dossier/Section II/Annex II_1_7.  
21 Technical Dossier/Section II/Annex II_1_10.  
22 Technical Dossier/Section II/Annex II_1_8.  
23 Technical Dossier/Section II/Annex II_1_11.  
24 Technical Dossier/Section II/Annex II_3_6.  
25 Technical Dossier/Section II/Annex II_3_7.  
26 Technical Dossier/Section II/Annex II_3_8.  
27 Technical Dossier/Section II/Annex II_4_1 and Annex II_4_2.  Aminotrace Copper Bislysinate for all animal species 
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2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of copper chelate 
of L-lysinate-HCl in animal feed. The Executive Summary of the EURL report can be found in the 
Appendix. 
3.  Safety  
3.1.  Safety for the target species 
3.1.1.  Tolerance studies for the target species 
The  applicant  has  provided  studies  on  calves,  chicken  for  fattening  and  piglets.  The  safety 
demonstration is based on the comparison of the effects of copper chelate of L-lysinate-HCl with a 
compound  of  trace  elements  already  authorised  (cupric  sulphate  pentahydrate)  at  different 
supplementation levels.  
3.1.1.1.  Tolerance study in calves  
Two 6-week tolerance trials were carried out with 60 Friesian male calves each (trial 1: initial age 18 
days, average body weight 51 kg; trial 2: initial age 12 days, average body weight 52 kg).
28 For each 
of the four treatments, 15 calves were housed together in one pen and fed individually by automatic 
feeders. A basal diet (milk replacer; background copper: 3 mg/kg feed) was supplemented with 7 and 
12 mg Cu/kg from cupric sulphate pentahydrate and copper chelate of L-lysinate-HCl, respectively in 
the first trial and with 7 and 42 mg Cu/kg in the second trial. The copper concentration in the diets was 
confirmed by analysis. During the trials, the animals received hay for ad libitum intake. Animals were 
medicated for the first ten days prophylactically against respiratory diseases
29 and diarrhoea,
30 and 
were vaccinated twice against the bovine respiratory syncytial virus and treated against endo- and 
ectoparasites.
31 The animals were weighed weekly; feed intake was recorded daily.  At the end of the 
trial, blood samples were  taken from  four  calves  per  treatment for haematology
32  and  clinical 
chemistry.
33 No statistics were provided.  
No conclusions on the safety of the copper compound under assessment can be drawn from this study 
with calves owing to several weaknesses in the design (absence of values for copper concentration in 
liver, which is used as a biomarker; absence of statistical evaluation; small number of animals used for 
haematology and clinical chemistry). It is noted that the feeding regime is considered untypical since 
no concentrate has been provided.  
3.1.1.2.  Tolerance study in chickens for fattening  
A 35-day tolerance study was performed in three consecutive experiments with a total of 600 two-day-
old chickens for fattening (Ross 308, both sexes).
34 In each experiment, 200 chickens for fattening 
were allocated to  two  dietary treatments, with  four  replicates of 25 chicken per treatment.  Each 
experiment was performed with a different copper supplementation level ( 12.5, 25 and 250 mg total 
Cu/kg feed). The diets of the control groups were supplemented with cupric sulphate pentahydrate and 
those of the treatment groups with copper chelate of L-lysinate-HCl. The basal diet, consisting mainly 
of maize and soybean meal (background copper: 7.5 mg/kg), was given as starter (days 0 10, 20 % 
crude protein (CP)) and grower (days 11 35, 19 % CP) diets.  
                                                       
28 Technical Dossier/Section III/Annex III_1_1 and Annex III_1_2. 
29   Non-steroidal anti-inflammatory substances. 
30   An aqueous extract of spruce needles. 
31   Pour-on-solution containing doramectin. 
32   Total  leucocytes,  erythrocytes,  platelets,  haemoglobin,  haematocrit,  mean  corpuscular  hemoglobin   (MCH),  mean 
corpuscular hemoglobin concentration (MCHC), mean cell volume (MCV). 
33   Albumin, urea, total protein, uric acid, aspartate transaminase (AST), gamma-glutamyl transferase (γ-GT). 
34   Technical Dossier/Section III/Annex III_1_3. Aminotrace Copper Bislysinate for all animal species 
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The intended copper concentration in the feed was confirmed by analysis (see Table 2). The birds 
were weighed and feed intake was recorded weekly. At the end of each experiment, samples (blood, 
liver, tibia) from eight broilers per experiment (presumably one broiler per replicate) were taken for 
haematology,
35 clinical chemistry
36 and copper analysis in liver and tibia. The statistical model applied 
was not reported. 
Mortality was low and not treatment related (Table 2). The zootechnical data are summarised in Table 
2. No effects of copper source and copper concentration on  body weight and feed-to-gain ratio were 
observed at dietary copper levels of 12.5 and 25 mg/kg . At  the highest copper concentration  (250 
mg/kg) birds in the copper lysinate group show ed a final weight which was about 30 % higher than 
that of the control (Table 2). It should be noted that the body weight of the birds in experiments 1 and 
2 and of the control group in experiment 3 was lower than expected for the broiler breed and  the 
duration of the experiment; this could be related to the low protein content, particularly of the grower 
diet. The lysine content of the grower diet (three analyses) was 0.83 %, which is considered low. The 
addition of about 240 mg copper from copper bislysinate would have increased dietary lysine to about 
0.98 %, which in turn might have resulted in a higher body weight. 
Some significant differences were observed in uric acid and albumin. However, considering the high 
variability of these parameters, the FEEDAP Panel considers that these observations did not indicate 
adverse effects.  Furthermore,  haematological  and  the  other clinical  chemical parameters  were  not 
affected by treatment. There were no substance-related differences in the copper concentration of liver 
and tibia. The copper level in liver appeared to be dose-dependent, as indicated by the values of the 
high-copper groups compared with the lower ones. It should however be mentioned that the standard 
deviation of the liver copper values in experiment 3 (four animals/treatment) is very high (169 ± 124 
and 126 ± 180 mg/kg dry matter (DM)). Thus, no conclusion can be drawn on the differences in the 
mean values observed in the copper sulphate and copper lysine complex groups. 
Table 2:   Effect of level and source of copper on performance and copper content in liver and tibia 
of chickens for fattening  
Experiment No.     1    2    3 
Cu source     CSP  CC-Lys    CSP  CC-Lys    CSP  CC-Lys 
Intended total copper  
(mg Cu/kg feed)  
  12.5     25     250 
Analysed copper  
(mg Cu/kg feed) 
  12.7  13.2    25.6  25.5    251.9  251.9 
Mortality n (out of 100)     3   2     2   2     3   0  
Final body weight (g)     1405   1384     1537   1541     1455   1916*  
Feed-to-gain  ratio     1.72   1.72     1.58   1.65     1.65   1.53  
Copper in liver  
(mg/kg DM)
1 
  12   12    10   11     169   126  
Copper in tibia  
(mg/kg fat‐free DM)
1  
  16  9    9  7    9   7  
(1) Four animals per treatment. 
* reported to be significantly different from cupric sulphate 250 mg/kg group (P≤ 0.05). 
CSP: Cupric sulphate pentahydrate; CC-Lys: Copper chelate of L-lysinate-HCl. 
There was no indication of differences between tolerance parameters for the two copper compounds, 
the chelate of L-lysinate-HCl and the sulphate pentahydrate, by chicken for fattening up to 10-fold the 
maximum authorised total copper in complete feed. The FEEDAP Panel notes that a small number of 
animals was used to analyse copper in the liver and tibia, as well as for the haematology and clinical 
chemistry analyses; therefore only limited conclusions can be drawn from this part of the study. 
                                                       
35 Total leucocytes, erythrocytes, haematocrit; only in experiments 2 and 3. 
36 Albumin, total protein, uric acid, AST, γ-GT. Aminotrace Copper Bislysinate for all animal species 
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3.1.1.3.  Tolerance study in weaned piglets  
A  42-day  tolerance  study  was  performed  with  72  weaned  piglets  (castrated  males  and  females; 
♂ Piétrain   ♀ (Euroc   German Landrace); age 25 days, average body weight: 6.7 kg). The piglets 
were allocated according to weight and sex to six dietary treatments (four replicates per treatment, 
three animals/replicate).
37 The basal diet (maize, wheat, barley and soybean meal; background copper 
concentration: 4 mg/kg feed) was supplemented with copper from cupric sulphate or copper chelate of 
L-lysinate-HCl to obtain diets with 6, 170 and 340 mg total Cu/kg, as confirmed by analysis (see Table 
3). The starter diet was fed for two weeks followed by a grower diet until completion of the study. 
Body weight and feed intake per pen were recorded weekly. At the end of the study, blood samples 
were taken from all animals for haematology
38 and clinical chemistry.
39 Copper in liver was analysed 
from  six  animals  per  treatment. An  analysis of variance  (ANOVA)  was done with the pen as 
experimental unit, followed by a Tukey post-hoc test.  
There was no mortality. Treatments did not significantly affect animal performance. The addition of 
approximately 0.1 and 0.2 % Lys to the diets with 170 and 340 mg total Cu/kg could be expected to 
improve the performance of piglets (lysine in starter and grower diets 1.12/1.03 %). This may be 
reflected in numerically better feed-to-gain ratios for the copper chelate treatments at the intermediate 
and high groups (Table 3). 
Although some significant differences were observed for neutrophils, mean corpuscular haemoglobin 
concentration, calcium, chlorine, cholesterol, urea and glucose, they are considered as not biologically 
relevant and mostly not dose- or substance-related. It should be noted that the means were always 
within the physiological range for piglets (Kraft and Dürr, 2005). Plasma copper was not affected by 
dietary copper from either source. No differences were seen in liver copper at 6 and 170 mg total 
Cu/kg feed, which is in accordance with a previous SCAN opinion (EC, 2003a). As concluded from 
the  same  opinion,  dietary  copper  higher  than  170  mg  would  result  in  increased  liver  copper 
concentrations, as shown in the present study from cupric sulphate, but not for the lysinate. It should 
be noted that the liver copper concentration of 340 mg Cu/kg feed in the cupric sulphate group was 
approximately half of that reported in the SCAN opinion at a comparable dose. 
Table 3:   Effect of level and source of copper on performance and copper content in blood and liver 
of piglets 
Cu Source     CSP  CC-Lys    CSP  CC-Lys    CSP  CC-Lys 
Intended total copper 
(mg/kg feed) 
  6    170    340  
Analysed copper  
(mg/kg feed) 
  6.2  6.3    180  181    350  350 
Total feed intake (kg/pig)    26.2  25.9    26.7  26.1    27.1  26.0 
Final body weight (kg)       20.6  20.9     21.6  22.5    22.7  22.8  
Feed-to-gain ratio    1.88   1.83     1.80   1.65     1.71   1.62  
Copper in blood  
(mg Cu/L)
1 
  1.6  1.6    1.6  1.6    1.6  1.6 
Copper in liver  
(mg Cu/kg DM)
2 
  78
a   84
a     88
a   83
a    106
b   82
a  
(1) Twelve animals per treatment. 
(2) Six animals per treatment. 
a,b: different superscripts within a row indicate statistical differences (P≤ 0.05). 
CSP: Cupric sulphate pentahydrate; CC-Lys: Copper chelate of L-lysinate-HCl. 
                                                       
37   Technical Dossier/Section III/Annex III_1_4 
38   Total and differential leucocyte counts, erythrocytes, haematocrit, haemoglobin, MCV, MCH, MCHC. 
39   Electrolytes (Na, K, Cl, Ca, P), cholesterol, triglycerides, bilirubin, urea, glucose, albumin, total protein,  AST, alanine 
aminotransferase (ALT) and alkaline phosphatase (ALP). Aminotrace Copper Bislysinate for all animal species 
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The study indicates that copper chelate of L-lysinate-HCl is equally tolerated as the cupric sulphate 
pentahydrate, by piglets up to 2-fold the maximum authorised total copper in complete feed for this 
species/category. 
3.1.2.  Conclusions on the safety for the target species 
Tolerance  studies  with  chicken  for  fattening  and  weaned  piglets,  allowed  the  FEEDAP  Panel  to 
conclude that copper chelate of L-lysinate-HCl does not elicit additional or different adverse effects in 
target species compared with the standard inorganic source cupric sulphate pentahydrate. Therefore, 
the FEEDAP Panel considers copper chelate of  L-lysinate-HCl as a safe source of copper  for all 
animal species, provided that the maximum copper contents authorised in feed are respected. 
3.2.  Safety for the consumer  
3.2.1.  Metabolic and residue studies  
Copper is absorbed from the diet in the upper jejunum by active and passive processes, stored in the 
liver and kidney, secreted in the bile and excreted in the faeces. Copper excretion via the kidneys is 
quantitatively insignificant if complex-forming substances are not administered (thiomolybdate from 
oral molybdenum in ruminants, dimethyl cysteine). Copper status is not easy to determine, and the 
homeostatic  mechanisms  that  control  copper  distribution  and  metabolism  are  not  completely 
understood.  Copper  interacts  with  other  divalent  cations,  such  as  calcium,  iron  and  zinc,  for 
gastrointestinal absorption  and  metabolism.  Absorption and availability  may  be  influenced by  the 
carbohydrate  content  of  the  diet,  with  reduced  availability  by  phytate  containing  diets  or  those 
containing fructose (EC, 2003b). The application of copper as a chelate complex with amino acids or 
other strong binding chelators may also affect absorption and bioavailability. 
The SCAN delivered an opinion on copper (EC, 2003a) in which the metabolism and tissue deposition 
of copper was reviewed. Other reviews are available from McDowell (2003) and Suttle (2010). The 
distribution of total copper in the body varies with species, age and copper status of the animal. In 
general, levels in newborn and suckling animals are higher, followed by a steady fall during growth to 
the time when adult values are reached. The main target organ for copper deposition is the liver. Other 
edible tissues containing high concentrations of copper are the heart, brain and kidney. Lower levels 
are found in muscle. Liver and kidney copper concentrations are related to dietary intake, whereas 
muscle  is  less  affected.  Its  presence in  milk  is  generally  very  low  and  not influenced  by  dietary 
supplementation levels. Clearance is higher in poultry than in mammals; the copper concentration in 
eggs is generally low. In fish, copper is primarily stored in the liver.  
For the assessment of copper deposition from the product under application in products of animal 
origin, only liver data were available. As stated above, the liver is the edible tissue with the highest 
affinity for copper deposition in food producing animals, as well as with deposition patterns readily 
influenced  by  dietary  intakes;  therefore  liver  deposition  can  be  taken  as  a  proxy  for  the  overall 
deposition of copper in edible tissues and products. Copper concentration in the tibia is considered as a 
reliable indicator of copper bioavailability. Two studies in two different target species (one on chicken 
for  fattening  and  one  on piglets;  see  sections  3.1.1.2  and  3.1.1.3)  submitted by  the  applicant  for 
tolerance in target species showed that the copper deposition in tibia bone from copper chelate of L-
lysinate-HCl was not higher than that from its standard inorganic source cupric sulphate pentahydrate 
when supplemented in feed up to the maximum authorised copper level in the EU; the similar response 
suggested  an  almost  equivalent  copper  bioavailability  from  the  two  sources,  providing  further 
reassurance that the supplementation with copper chelate of  L-lysinate-HCl would not result in an 
increased deposition of copper compared with inorganic sources. This conclusion is also supported by 
Jongbloed et al. (2002) who evaluated that copper from copper chelate of L-lysinate-HCl and cupric 
sulphate pentahydrate have equivalent bioavailabilities in terms of liver copper deposition based on a 
review of two studies on pigs (Coffey at al., 1994; Apgar et al., 1995), three on poultry (Baker et al., 
1991; Aoyagi and Baker, 1993; Pott et al., 1994) and three in ruminants (Pott et al., 1994; Luo et al., 
1996;  Chase  et  al.,  2000).  Although  some  of  these  reviewed  studies  used  supplementation levels Aminotrace Copper Bislysinate for all animal species 
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leading  to  feed  copper  levels  considerably  higher  than  those  currently  authorised,  none  of  them 
showed a significantly higher copper liver deposition from copper chelate of L-lysinate-HCl than from 
cupric sulphate pentahydrate. 
The amount of lysine as an essential amino acid released from the dissociation of copper chelate of L-
lysinate-HCl in the animal body after its oral intake will be limited by the maximum authorised copper 
level in animal feed and this lysine will be used in protein synthesis and/or metabolised to urea and 
carbon dioxide without any modification of edible tissues/products. 
The FEEDAP Panel considers that copper from copper chelate of L-lysinate-HCl would not result in 
a different  copper  deposition  in  edible  tissue/products  than  the  standard  inorganic  source  cupric 
sulphate pentahydrate when supplemented to feed up to the maximum authorised copper level in the 
EU. 
The supplementation of feeds with copper from copper chelate of L-lysinate-HCl up to the maximum 
authorised  copper  levels  is  not  expected  to  result  in  a  different  copper  deposition  in  edible 
tissues/products than the standard inorganic source cupric sulphate pentahydrate. No concerns for 
consumer safety will arise from the use of the additive in animal nutrition, provided that the maximum 
copper contents authorised in feed are respected. 
3.2.2.  Toxicological studies  
No specific toxicological studies with the product under assessment were submitted. The compound 
copper chelate of L-lysinate-HCl is expected to be dissociated in the target animal and, consequently, 
only copper is considered for potential toxicological concerns for consumers. 
The Scientific Committee on Food (SCF) (EC, 2003b) summarised data on the toxic properties of 
copper. Tolerance to high intakes of copper varies greatly from one species to another, in relation to 
the vulnerability of the species and the levels of zinc, iron and molybdenum in the diet. Copper excess 
causes impaired growth and extensive necrosis of hepatocytes. Susceptibility to copper excess is also 
influenced  by  its  chemical  form.  Manifestations  of  copper  toxicity  include  weakness,  tremors, 
anorexia and jaundice. As tissue copper levels increase, haemolytic crisis may ensue, resulting in liver, 
kidney and brain damage.  
3.2.2.1.  Genotoxicity/Mutagenicity/Carcinogenicity  
Copper(II)  has  been  reported  to  be  genotoxic  in  vitro  and  also  in  some  in  vivo  bone  marrow 
micronucleus assays in mice after intraperitoneal injection. As with other essential trace elements 
(zinc, iron), copper is known to have a genotoxic potential when present at high local concentrations. 
In  particular,  copper  is  a  redox-active  transition  element,  potentially  able  to  catalyse  the 
Fenton/Haber–Weiss reaction, with the consequent production of reactive oxygen species. As copper 
is physiologically present in the intracellular environment at very low levels, a genotoxic concern for 
the human population is not foreseen, except under conditions of overload, which are not relevant to 
the use of the additive under evaluation.  
The International Agency for Research on Cancer (IARC) allocated copper (II) 8-hydroxyquinoline to 
Group 3 ―Not classifiable as to their carcinogenicity to humans‖ (IARC, 1987). The SCF (EC, 2003b) 
concluded that studies on the carcinogenicity of copper compounds in rats and mice have given no 
indication of carcinogenic potential; however, some degree of uncertainty exists owing to limitations 
in available studies.  
3.2.2.2.  Reproduction toxicity  
With regard to the influence on reproduction, studies in rodents demonstrated that oral exposure to 
copper  during  gestation  induced  embryo/fetotoxic  and  developmental  effects.  Copper(II)  sulphate 
administered at doses of 12 and 80 mg Cu per kg body weight and day was embryolethal to mink and 
mice, respectively (IPCS, 1998).  Aminotrace Copper Bislysinate for all animal species 
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3.2.3.  Assessment of consumer safety  
A tolerable upper intake level (UL) of 5 mg Cu/day for adults and 1 mg/day for toddlers (one to three 
years of age) was defined by the SCF (EC, 2003b). This figure was derived from an overall no 
observed adverse effect level (NOAEL) of 10 mg Cu/day identified in the study by Pratt et al. (1985) 
(daily single dose levels only administered to seven male adult volunteers for 12 weeks, with serum 
liver markers as endpoints), applying an uncertainty factor of 2 for potential variability in the normal 
population.  
Studies on copper dietary intakes in industrialised countries did provide comparable results. Mean 
dietary copper intakes by adults in different European countries have been estimated to be within a 
range of about 1.0-2.0 mg/day (Van Dokkum, 1995; EC, 2003b; Sadhra et al., 2007; Rubio et al., 
2009;  Turconi  et  al.,  2009).  Based  on  11  independent,  peer-reviewed  surveys  considering  only 
analytically confirmed copper (n= 849) in Belgium, Canada, the United Kingdom and the USA, the 
mean copper intakes for men and women were estimated to be 1.48 (2.87 for P95) and 0.92 (2.18 for 
P95) mg/day, respectively (Klevay, 2011). A recent analytical study of Catalonian diets showed a 
copper intake of 1.2 mg/day (Domingo et al., 2012). It has been suggested that calculated copper 
intakes are overestimated when only food composition tables are used in nutrition surveys (Klevay, 
2012).  
Among edible tissues of animal origin, the highest concentration of copper is found in liver (the main 
deposition organ), followed by kidney and muscle. Among products of animal origin, milk shows the 
lowest values.  
The supplementation of feeds with copper from copper chelate of  L-lysinate-HCl up to maximum 
authorised  copper  level  is  not  expected  to  result  in  a different  copper  deposition  in  edible 
tissue/products than the standard inorganic source cupric sulphate pentahydrate (section 3.2.1.). Since 
the  supplementation  of  animal  feed  with  copper-containing  compounds  has  not  been  essentially 
changed over the last decade, the use of the additive under application would not modify the consumer 
exposure to copper. The FEEDAP Panel concludes that copper chelate of L-lysinate-HCl is safe for 
consumers when used in animal nutrition according to the legislation. 
The  FEEDAP  Panel  reconfirms  its  previous  proposal  concerning  the  modification  of  the  current 
maximum residue limits for copper in animal tissues and products (EFSA FEEDAP Panel, 2012). 
3.2.4.  Conclusions on the safety for the consumer 
The supplementation of feeds with copper from copper chelate of L-lysinate-HCl up to the maximum 
authorised  copper  levels  is  not  expected  to  result  in  a  different  copper  deposition  in  edible 
tissues/products than the standard inorganic source  cupric sulphate pentahydrate. No concerns for 
consumer safety will arise from the use of the additive in animal nutrition, provided that the maximum 
copper contents authorised in feed are respected. 
3.3.  Safety for the user  
3.3.1.  Effects on the respiratory system  
The powder form of copper chelate of L-lysinate-HCl shows a significant dusting potential (up to 5.1 
g/m
3). About 96 % of particles of the dust have a diameter   10 µm. Considering the theoretical copper 
content of the dust (about 14 %), the absence of inhalation toxicity studies and the possible hazardous 
effects of inhaled copper, in particular for the immune response of the lungs (EFSA FEEDAP Panel, 
2012; EC, 2013), handling the product should be considered as a risk by inhalation. Granulating the 
copper chelate of l-lysinate-HCl reduces the dusting potential of the powder by a factor of 100 (0.05 
g/m
3),  and  because  of  the  virtual  absence  of  particle  of  respirable  size,  the  risk  of  exposure  by 
inhalation is minimised. Aminotrace Copper Bislysinate for all animal species 
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3.3.2.  Effects on the eyes and skin  
Good Laboratory Practice-compliant tests were conducted in rabbits for dermal irritation (according to 
the Organisation for Economic Co-operation and Development (OECD) testing guideline 404)
40 and 
eye irritation (according to OECD testing guideline 405)
41 with both forms of the additive.  
Both forms of the additive produced reversible dermal irritation, which was slight to moderate for the 
powder form and very slight for the granulate form. Similarly, both forms of the additive  produced 
reversible ocular reactions; for the powder  form this reaction was moderate,  and, for the granulate 
form, only a slight irritation was produced.   
No skin sensitisation studies were performed. In the absence of specific information , the FEEDAP 
Panel considers it prudent to regard the additive as a potential skin sensitiser. 
3.3.3.  Conclusions on the safety for users/workers 
The powder form of copper chelate of L-lysinate-HCl should be considered as a risk by inhalation; 
exposure by inhalation should be minimised. Neither form of the additive is a not dermal irritant but 
the powder form is an eye irritant. In the absence of data, it is considered prudent to regard both forms 
as potential skin sensitisers. 
3.4.  Safety for the environment  
The FEEDAP Panel has already considered the potential risks to the environment posed by the use of 
copper in feedingstuffs up to the maximum authorized contents in the EU (EFSA FEEDAP Panel, 
2012). The additive under assessment, copper chelate of L-lysinate-HCl, is intended to be a substitute 
for other authorised copper additives. It will therefore not further increase the environmental burden of 
copper. 
4.  Efficacy  
The applicant provided two trials to demonstrate the efficacy of copper chelate of L-lysinate-HCl, one  
with chicken for fattening and another with weaned piglets. In both experiments the efficacy of copper 
chelate of L-lysinate-HCl was compared with cupric sulphate pentahydrate. In addition the FEEDAP 
Panel identified a study with chicken for fattening from the available literature to evaluate the efficacy 
of the compound under assessment. 
4.1.  Chickens for fattening 
4.1.1.  Study 1 
The applicant submitted a study with chickens for fattening to support the efficacy of the additive. 
This  study  has  already  been  described  in  section  3.1.1.2.  No  differences  in  the  liver  copper 
concentration between the two copper sources, the L-lysinate-HCl and the sulphate, were found at the 
three dietary levels tested.   
A considerable increase in liver copper could be seen as a consequence of an increase of dietary 
copper from 12/25 mg/kg to 250 mg/kg. This increase was observed for both copper sources (Table 2). 
4.1.2.  Study 2 
This study, in which  two independent experiments with chicken were performed, was taken from the 
literature  (Guo  et  al.,  2001).  The  exact  composition  of  the  copper  lysine  complex  used  was  not 
described. The copper and nitrogen contents were 10.1 and 7.77 %, respectively. The additive in the 
present opinion has a copper content of 14.5 % and a nitrogen content (calculated from lysine HCl) of 
                                                       
40  Technical Dossier/Section III/Annex III_3_5 and Annex III_3_7.  
41  Technical Dossier/Section III/Annex III_3_6 and Annex III_3_8 . Aminotrace Copper Bislysinate for all animal species 
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13.1 %, with a copper:lysine ratio of 1:2. The corresponding copper:lysine ratio of the copper-lysine 
complex  used by  Guo  et al. is  1:1.74. Thus, this  copper-lysine  complex contains other  unknown 
ingredients and an insufficient relative concentration of lysine to form a complete bivalent complex 
with copper. However, the Cu:Lys ratio is relatively close to 1:2. It can therefore be suggested that the 
copper predominantly exists in the studied product as a bivalent complex with lysine. 
In each of the two experiments, five pens of five-day-old male chicks were used for each of the five 
dietary treatments. The treatments were 150, 300 and 450 mg Cu supplemental as reagent-grade Cu 
sulphate/kg or 150 and 300 mg Cu supplemental as copper lysine complex/kg basal diet. The basal 
maize-soybean meal diet contained 16 and 22 mg Cu/kg DM in experiments 1 and 2, respectively. The 
concentration of copper in the diets was confirmed by analysis. At the end of the experiment (21 and 
20 days in experiments 1 and 2, respectively), body weight and feed consumption were recorded. 
Copper in liver was analysed in five and three chickens per pen in experiments 1 and 2, respectively. 
Data were analysed by two-way ANOVA. 
Considering the duration of the experiments, both are regarded as bioavailability studies; only the 
copper deposition in liver is described. Copper supplementation of 150 to 300 mg/kg feed, using 
cupric sulphate as copper source, resulted in an increase of liver copper from 21 mg/kg DM to 124 
mg/kg DM (averages of both experiments). The corresponding figures after the addition of 150 and 
300 mg Cu/kg feed from copper lysinate were 29 and 147 mg Cu/kg liver DM, resèctively. 
4.2.  Weaned piglets 
This study has already been described in section 3.1.1.3. Copper concentration of the liver is the best 
parameter to demonstrate bioavailability of the copper source; however, feed concentration needs to be 
above the maximum authorised level for demonstration. No dose-dependent increase in liver copper 
with application of the additive, was observed in this study, even at the highest concentration used 
(350 mg/kg feed). For cupric sulphate a marginal increase in liver copper was observed at 350 mg/kg 
feed (see also Table 3). Therefore, the data do not provide clear indication of copper availability for 
both substances (copper chelate of L-lysinate-HCl and copper sulphate). 
4.3.  Conclusions on the efficacy for the target species 
Liver copper concentration is considered a valid biomarker for the bioavailability of dietary copper. A 
response in some species (pigs and chickens) can be seen only at high copper levels in feed. In one 
study in chickens, dietary copper chelate of L-lysinate-HCl increased the copper concentration in liver 
in a dose-dependent manner comparable to a standard authorised copper source; an additional study in 
chickens also supported the bioavailability of copper from a copper-lysine complex. Based on the 
evaluation  of  liver  deposition  data  in  comparison  with  a  standard  inorganic  copper  source,  it  is 
therefore concluded  that  copper chelate  of  L-lysinate-HCl  is  efficacious  as a source  of copper in 
meeting the requirements of all animal species.   
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
42  and  Good 
Manufacturing Practice. 
                                                       
42   Regulation  (EC)  No  183/2005  of  the  European  Parliament  and  of  the  Council  of  12  January  2005  laying  down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Aminotrace Copper Bislysinate for all animal species 
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Tolerance studies provided with chickens for fattening and weaned piglets allowed the FEEDAP Panel 
to conclude that copper chelate of L-lysinate-HCl is a safe source of copper for all species, provided 
that the maximum copper contents authorised in feed are respected.  
The supplementation of feeds with copper from copper chelate of L-lysinate-HCl up to the maximum 
authorised  copper  levels  is  not  expected  to  result  in  a  different  copper  deposition  in  edible 
tissues/products than the standard inorganic source cupric sulphate pentahydrate. No concerns for 
consumer safety will arise from the use of the additive in animal nutrition, provided that the maximum 
copper contents authorised in feed are respected. 
The powder form of copper chelate of L-lysinate-HCl should be considered as a risk by inhalation; 
exposure by inhalation should be minimised. Neither form of the additive is a dermal irritant but the 
powder form is an eye irritant. In the absence of data, it is considered prudent to regard both forms as 
potential skin sensitisers. 
Copper chelate of L-lysinate-HCl, is intended to be a substitute for other authorised copper additives; it 
will therefore not further increase the environmental burden from copper. 
Copper chelate of L-lysinate-HCl is an efficacious source of copper for all animal species.  
RECOMMENDATIONS 
In order to avoid confusion with other copper chelates of lysine containing 1 mol copper with 1 mol of 
Lys,  the  FEEDAP  Panel  recommends  ―Copper  bislysinate‖  for  the  name  of  the  additive  under 
assessment. 
The description of the additive should include the copper and lysine contents. The proposed figures are 
≥ 14.5 % copper and ≥ 84.0 % lysine, for both forms of the additive. 
The complex contains two molecules of hydrochloric acid, and therefore the molecular formula is: 
Cu(C6H13N2O2)2×2HCl. 
The lysine content of the additive should be considered when formulating feed for piglets. 
The  FEEDAP  Panel  reiterates  its  previous  proposal  concerning  the  modification  of  the  current 
maximum residue limits for copper in animal tissues and products (EFSA FEEDAP Panel, 2012). 
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APPENDIX 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for Aminotrace Copper Bislysinate
43 
In the current application authorisation is sought under article 4(1) for Copper Chelate of L-Lysinate-
HCl under the category/ functional group (3b) "nutritional additives"/"compounds of trace elements", 
according to the classification system of Annex I of Regulation (EC) No 1831/2003. Specifically, 
authorisation is sought for the use of the feed additive for all categories and species. 
Copper Chelate of L-Lysinate-HCl is a dark-grey or black free flowing powder or granules with a 
minimum content of 14.5 % total copper, and a maximum content of 85.5 % L-Lysine-HCl. 
The feed additive is intended to be incorporated into premixtures and feedingstuffs. The Applicant 
suggested  maximum  levels  of  total  copper  in  the  feedingstuffs  complying  with  the  limits  set  in 
Regulations (EC) No 1334/2003 and 479/2006, and ranging from 15 to 170 mg/kg, depending of the 
animal species/category. 
For the quantification of Lysine content in the feed additive the Applicant submitted the ring-trial 
validated  VDLUFA  method,  based  on  ion-exchange  chromatography  coupled  with  post-column 
derivatisation  and  colourimetric  or  fluorescence  detection.  However,  the  EURL  identified  and 
recommends instead the recently published ring-trial validated EN ISO 17180 method - based on a 
similar analytical protocol - for the "determination of Lysine […] in commercial amino acid products 
and  premixtures".  The  following  performance  characteristics  were  reported  for  Lysine  contents 
ranging from 100 to 740 g/kg: - a relative standard deviation for repeatability (RSDr) ranging from 0.7 
to 1.7 %; and - a relative standard deviation for reproducibility (RSDR) ranging from 1.5 to 2.5 %. 
For the determination of total copper in the feed additive, premixtures and feedingstuffs the Applicant 
submitted the internationally recognised ring-trial validated method EN 15510 based on inductively 
coupled plasma atomic emission spectroscopy (ICP-AES). The following performance characteristics 
were reported for the copper content ranging from 6.8 to 775 mg/kg premixtures and feedingstuffs: - 
RSDr ranging from 2.9 to 12 %; RSDR ranging from 8 to 22 %; and - a limit for quantification (LOQ) 
of 3 mg/kg feedingstuffs. 
Additionally, the EURL already recommended in the frame of the Copper group evaluation (cf. Final 
report JRC.D.5/CvH/PRO/ago/ARES(2012)108233) the ring-trial validated EN 15621 method, based 
on ICP-AES after pressure digestion. The following performance characteristics were reported for a 
copper content ranging from 7.3 to 470 mg/kg: - RSDr ranging from 2.6 to 6.8 %; - RSDR ranging 
from 3.8 to 12 %; and - LOQ = 1 mg/kg feedingstuffs. Furthermore, a Community method is available 
for  the  determination  of  total  copper  in  feedingstuffs,  but  no  performance  characteristics  for  the 
method are available, except an LOQ of 10 mg/kg feedingstuffs. However, the UK Food Standards 
Agency recently published a ring-trial based on the above mentioned Community method and reported 
precisions (RSDr and RSDR) from 2.4 to 9.2 % for copper contents ranging from 17 to 39 mg/kg 
feedingstuffs. Based on the available information the EURL recommends for official control the two 
CEN methods (EN 15510 or EN 15621) together with the Community method (Com Reg (EC) No 
152/2009 – Annex IV-C) for the determination of total copper in the feed additive, premixtures and 
feedingstuffs. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
                                                       
43   The full report is available on the EURL website: http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
2013-0003_Copper_Lysinate.pdf 